Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nearly 20 Emerging Medical Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innovation (In

Abstract:
February 27-29, 2008, Las Vegas, NV, The Venetian Hotel

Nearly 20 Emerging Medical Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innovation (In

NEWPORT BEACH, CA | Posted on November 1st, 2007

Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that nearly 20 promising young medical device companies are already confirmed to present at its "Investment In Innovation (In3) West" conference, being held February 27-29, 2008 at The Venetian Resort-Hotel-Casino in Las Vegas, Nevada. The two-day In3 West event ( http://www.windhover.com/in3west08 ) - the company's 29th In3 conference - will showcase a total of over 50 innovative young medtech companies from around the world presenting (many for the first time on our stage) to an audience of 250+ senior business development and investment executives from the leading medical technology and healthcare investment firms, for purposes of raising funding or forming strategic partnerships.

Presentations from a group of cutting-edge early- to late-stage companies, carefully selected by our Advisory Board of expert healthcare investment professionals, will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few. Presenters confirmed to date include AVAcore Technologies, Cardiac Output Technologies, Cohera Medical, CoreSpine Technologies, Deca-Medics, eCardio Diagnostics, EyeTect, HealthLink Europe, Infrared Sciences, Light Sciences Oncology, Moerae Matrix, Nesos Health, Photo Dynamic Therapy, Portland Orthopaedic, Praxim, Provista Life Sciences, TheraCardia, and ValveXchange, among many others being added to the program regularly.

The In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature a presenting company product exhibition/networking reception, plenary sessions by device industry thought leaders, a Manufacturer Perspective panel discussion/case study titled "What Are Buyers Looking for in 2008?", a Venture Perspective panel discussion/case study, "Doing Innovative or Unconventional Deals," educational workshops for start-up companies, and much more. Various event co-sponsors to be announced.

Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 7 years.

To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail . Attendees can register on the Medtech Insight website at http://www.windhover.com/in3west08 ; the early bird $1195 attendee registration rate ($300 off the regular rate) expires November 16, 2007.

See http://www.medtechinsight.com/pastpresenters.html for a full list of previous Medtech Insight conference presenters and their technology descriptions. To read what past attendees and industry experts think of Medtech Insight's investment and partnering events, please visit http://www.medtechinsight.com/in3success.html .

Medtech Insight and Windhover Information will also be holding three additional "Investment In Innovation" events in 2008. For more information on any of these conferences, please call Medtech Insight or visit the company's website at http://www.medtechinsight.com/conferences.html .

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight
a division of Windhover Information Inc.
Kristy Grimes
480-985-9512
or 888-202-5939 toll-free in the U.S.

http://www.windhover.com

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Investments/IPO's/Splits

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanomedicine

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3ís significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Announcements

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Events/Classes

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

Leti Will Present 11 Papers and Host More-than-Moore Technologies Workshop November 14th, 2017

TUBALL nanotube-based concentrates recognised as the most innovative raw material for composites by JEC Group November 7th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project